The Centers for Medicare and Medicaid Services said late Friday that it would not cover medications such as Wegovy that are used to treat obesity

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the federal government's Medicare program. CMS said late Friday that it would not cover the medications under Medicare's Part D prescription drug coverage. Medicare covers health care expenses mainly for people ages 65 and older.